Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis

Leuk Res. 2006 Jun;30(6):761-3. doi: 10.1016/j.leukres.2005.07.013. Epub 2005 Sep 2.

Abstract

It has been reported that malignancies of natural killer (NK) cell precursors, which are present in both myeloid and lymphoid antigens, are characterized by immature lymphoblastoid morphology with CD7+, CD33+ and CD56+ phenotype. Here, we report a 18-year-old man who was diagnosed with CD33- and CD13- NK cell precursor acute leukemia at first diagnosis. Following a 3-year remission state, he had a relapse as a testicular tumor and CD33+ myeloid/NK cell precursor acute leukemia after allogenic BMT. This case suggests that myeloid antigens are not necessary for diagnosis of myeloid/NK cell precursor acute leukemia.

MeSH terms

  • Adolescent
  • Antigens, CD / blood*
  • Antigens, CD7 / blood
  • Antigens, Differentiation, Myelomonocytic / blood*
  • Bone Marrow Transplantation
  • CD13 Antigens / blood*
  • CD56 Antigen / blood
  • Humans
  • Killer Cells, Natural* / pathology
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Recurrence
  • Sialic Acid Binding Ig-like Lectin 3
  • Testicular Neoplasms / blood*
  • Testicular Neoplasms / diagnosis*
  • Testicular Neoplasms / pathology
  • Transplantation, Homologous

Substances

  • Antigens, CD
  • Antigens, CD7
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • CD56 Antigen
  • Sialic Acid Binding Ig-like Lectin 3
  • CD13 Antigens